Zhao Xiangmei, Yang Xianzhi, Gao Chuanyu, Chu Yingjie, Yang Lei, Tian Lixiao, Li Lin
Deparment of Emergency, Zhengzhou University People's Hospital, Zhengzhou, Henan, China (mainland).
Deparment of Cardiology, Zhengzhou University People's Hospital, Zhengzhou, Henan, China (mainland).
Med Sci Monit. 2017 Feb 27;23:1055-1063. doi: 10.12659/msm.902466.
BACKGROUND This study sought to compare the 30-day and 1-year survival of patients diagnosed with ST-segment elevation myocardial infarction (STEMI), whose symptom onset to in-hospital first medical contact (IHFMC) was 3-6 h, who received either in-hospital thrombolysis (IHT) in the nearest county hospital or direct transfer to a larger hospital in Henan province, China for primary percutaneous coronary intervention (PPCI). MATERIAL AND METHODS Patients were allocated into 2 groups: one group received IHT in the local county hospital, whereas the other group were transferred to the PCI centers to receive PPCI. Patient demographic data, baseline characteristics, and time between different stages of patient contact to the initiation of treatment for IHT or PPCI were recorded for analysis. RESULTS No significant difference was identified between the 2 groups with the baseline characteristics and demographic data. The all-cause mortality was not significantly different between the IHT and PPCI group at 30 days (13.0% vs. 9.9%, p=0.386). However, a significant difference in mortality between the IHT and PPCI group was observed at 1 year (23.4% vs. 14.1%, p=0.035). Inter-hospital transfer time for PPCI tended to be the independent predictor for survival (OR: 4.4 CI 95%: 1.9-14.5, p 0.001). Overall, the patients undergoing PPCI in inter-hospital transfer had a higher survival rates for 1 year compared with patients receiving IHT. CONCLUSIONS Despite the delay associated with inter-hospital transfer for PPCI, patients with STEMI 3-6 h after symptom onset have improved survival with PPCI over patients treated locally with IHT.
背景 本研究旨在比较症状发作至首次住院医疗接触(IHFMC)时间为3 - 6小时、诊断为ST段抬高型心肌梗死(STEMI)的患者的30天和1年生存率,这些患者要么在最近的县级医院接受院内溶栓(IHT),要么直接转至中国河南省一家更大的医院进行直接经皮冠状动脉介入治疗(PPCI)。
材料与方法 将患者分为两组:一组在当地县级医院接受IHT,而另一组转至PCI中心接受PPCI。记录患者人口统计学数据、基线特征以及从患者接触不同阶段到开始IHT或PPCI治疗的时间,用于分析。
结果 两组在基线特征和人口统计学数据方面未发现显著差异。IHT组和PPCI组在30天时的全因死亡率无显著差异(13.0%对9.9%,p = 0.386)。然而,IHT组和PPCI组在1年时的死亡率存在显著差异(23.4%对14.1%,p = 0.035)。PPCI的院间转运时间倾向于成为生存的独立预测因素(OR:4.4,95%CI:1.9 - 14.5,p < 0.001)。总体而言,与接受IHT的患者相比,在院间转运中接受PPCI的患者1年生存率更高。
结论 尽管PPCI的院间转运存在延迟,但症状发作后3 - 6小时的STEMI患者接受PPCI后的生存率高于在当地接受IHT治疗的患者。